UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients

Journal of neurology, 2019-01, Vol.266 (1), p.183-194

2019

Volltextzugriff (PDF)

Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis

Journal of neurology, neurosurgery and psychiatry, 2020-09, Vol.91 (9), p.1007-1009

2020

Volltextzugriff (PDF)

Low T-cell reactivity to TDP-43 peptides in ALS

Frontiers in immunology, 2023-07, Vol.14, p.1193507-1193507

2023

Volltextzugriff (PDF)

Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials

Translational neurodegeneration, 2021-08, Vol.10 (1), p.31-31, Article 31

2021

Volltextzugriff (PDF)

Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment

Therapeutic advances in neurological disorders, 2019, Vol.12, p.1756286419846058-1756286419846058

2019

Volltextzugriff (PDF)

Quality of Life in SMA Patients Under Treatment With Nusinersen

Frontiers in neurology, 2021-03, Vol.12, p.626787-626787

2021

Volltextzugriff (PDF)

ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale

Neurological research and practice, 2022-12, Vol.4 (1), p.60-60, Article 60

2022

Volltextzugriff (PDF)

Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen

Frontiers in neurology, 2019-11, Vol.10, p.1179-1179

2019

Volltextzugriff (PDF)

Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial

Trials, 2017-07, Vol.18 (1), p.358-358, Article 358

2017

Volltextzugriff (PDF)

Biomarkers for amyotrophic lateral sclerosis

Current opinion in neurology, 2022-10

2022

Volltextzugriff (PDF)

Aktuelle und zukünftige Therapieansätze bei der amyotrophen Lateralsklerose

InFo Neurologie + Psychiatrie, 2019-09, Vol.21 (9), p.30-37

2019

Volltextzugriff (PDF)

Amyotrophe Lateralsklerose – ein Update zu Diagnostik, Therapie und Forschung

Neurologie up2date, 2019-05, Vol.2 (2), p.191-209

2019

Volltextzugriff (PDF)

Mutation‐specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis

European journal of neurology, 2023-01, Vol.30 (1), p.87-95

2023

Volltextzugriff (PDF)

Stellenwert der Adenosin-Stress-Magnetresonanztomographie bei der stabilen koronaren Herzkrankheit

Witzel, Simon

2019

Volltextzugriff (PDF)

Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled study

Journal of neurology, neurosurgery and psychiatry, 2022-03, Vol.93 (3), p.298-302

2022

Volltextzugriff (PDF)

Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis

Brain (London, England : 1878), 2023-09, Vol.146 (9), p.3770-3782

2023

Volltextzugriff (PDF)

Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis—insights from a completed randomized controlled trial with rasagiline

European journal of neurology, 2024-03, Vol.31 (3), p.e16154-n/a

2024

Volltextzugriff (PDF)

Fast versus slow disease progression in amyotrophic lateral sclerosis–clinical and genetic factors at the edges of the survival spectrum

Neurobiology of aging, 2022-11, Vol.119, p.117-126

2022

Volltextzugriff (PDF)

Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohort

Journal of neurology, neurosurgery and psychiatry, 2024-08, Vol.95 (8), p.737-747

2024

Volltextzugriff (PDF)

Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen

Journal of neurology, 2020, Vol.267 (1), p.36-44

2020

Volltextzugriff (PDF)

Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled Trial

JACC. Cardiovascular imaging, 2018-07, Vol.11 (7), p.987-996

2018

Volltextzugriff (PDF)

ALS is imprinted in the chromatin accessibility of blood cells

Cellular and molecular life sciences : CMLS, 2023-05, Vol.80 (5), p.131-131, Article 131

2023

Volltextzugriff (PDF)

Clinical characterization of common pathogenic variants of SOD1-ALS in Germany

Journal of neurology, 2024-10, Vol.271 (10), p.6667-6679

2024

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(102)
Deutsch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients

Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis

Low T-cell reactivity to TDP-43 peptides in ALS

Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials

Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment

Quality of Life in SMA Patients Under Treatment With Nusinersen

ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale

Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen

Magnetic resonance Adenosine perfusion imaging as Gatekeeper of invasive coronary intervention (MAGnet): study protocol for a randomized controlled trial

Biomarkers for amyotrophic lateral sclerosis

Aktuelle und zukünftige Therapieansätze bei der amyotrophen Lateralsklerose

Amyotrophe Lateralsklerose – ein Update zu Diagnostik, Therapie und Forschung

Mutation‐specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis

Stellenwert der Adenosin-Stress-Magnetresonanztomographie bei der stabilen koronaren Herzkrankheit

Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled study

Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis

Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis

Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis—insights from a completed randomized controlled trial with rasagiline

Fast versus slow disease progression in amyotrophic lateral sclerosis–clinical and genetic factors at the edges of the survival spectrum

Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohort

Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen

Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled Trial

Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis

ALS is imprinted in the chromatin accessibility of blood cells

Clinical characterization of common pathogenic variants of SOD1-ALS in Germany

Suchergebnisse filtern